Rooibos Aspalathus linearis (Burm.f.) R.Dahlgren
Also called: redbush, red bush tea, Psoralea linearis Burm.f. (synonym)
Rooibos is a South African shrub whose dried leaves are brewed as a naturally caffeine-free herbal tea, drunk fermented (traditional) or unfermented (green). Human research is limited to a few small studies.
- Category
- Botanical
- Part used
- Leaves and fine stems, as tea (fermented or unfermented) or extract
- Strongest evidence
- C Limited
- Native range
- Native to the Cape Provinces of South Africa (POWO: "Cape Prov.")
- Reviewed
- 2026-10-29
Class 2 Moderately studied in people. No review of human trials was found (source 6 pooled rodent studies). This entry cites 3 RCTs of rooibos alone: sources 3-5, tea or extract capsules versus another drink or placebo, plus one non-randomized controlled study (source 2). [3]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CMuscles and exercise1 topic
DBlood sugar and weight1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood lipids and oxidative stress in adults at cardiovascular risk | C | 40 adults drank six cups of fermented rooibos daily for 6 weeks, compared with a control period: LDL cholesterol and triglycerides fell and HDL rose; the study had no placebo group. [2] |
| Angiotensin-converting enzyme (ACE) activity in healthy volunteers | C | In a randomized crossover study of 17 volunteers, a single 400 ml dose of rooibos inhibited ACE activity at 30 and 60 minutes; nitric oxide did not change. Blood pressure was not an outcome. [3] |
| Heart structure and function in adults at cardiovascular risk | C | A 12-week randomized, placebo-controlled trial of green and fermented rooibos extract capsules reported mixed echocardiography changes, some also in the placebo group. [4] |
| Rehydration after exercise-induced dehydration | C | In a randomized crossover study of 23 collegiate wrestlers dehydrated by 3% of body mass, rooibos tea was no more effective than plain water for rehydration. [5] |
| Blood glucose in diabetic rodents | D | A meta-analysis of 12 rodent studies found lower blood glucose with rooibos extracts or their polyphenols, with substantial heterogeneity; no human data were included. [6] |
Main constituents: Polyphenols, especially the dihydrochalcones aspalathin and nothofagin; no catechins (the main flavonoids of green and black tea) [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Six cups of fermented/traditional rooibos daily for 6 weeks (lipid study). [2]
- A single 400 ml serving (ACE study). [3]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)See details
No NIH LiverTox chapter on rooibos was found. MSK lists three case reports of liver toxicity or raised liver enzymes with long-term or large intake …
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines2 listed
Tacrolimus; CYP3A substrate drugs
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Three case reports describe liver toxicity or raised liver enzymes with long-term or large intake of rooibos tea (one with low platelets); in two, liver tests returned to normal after stopping. [1]
- Compounds isolated from rooibos leaves showed estrogenic activity; MSK advises people with hormone-sensitive cancers to use caution. [1]
- Rat studies suggest prolonged exposure may affect the reproductive system, fertility, or liver and kidney function; MSK notes this has not been confirmed in humans. [1]
- Retail rooibos samples from 18 European countries contained pyrrolizidine alkaloids (98% of 203 samples) and Alternaria mycotoxins; 2024 samples were below the EU limit of 400 μg/kg. [7]
Interactions
| With | What happens |
|---|---|
| Tacrolimus | In a bone marrow transplant recipient, drinking more than 2 liters of rooibos a day lowered tacrolimus levels, followed by graft-versus-host disease (single case). [1] |
| CYP3A substrate drugs | Rooibos induced CYP3A in animal studies and might lower levels of these drugs; clinical relevance has not been determined. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Pyrrolizidine alkaloids (mainly Senecio-type) and Alternaria toxins transferred into infusions in testing; a comparison of 2020 to 2026 results suggested lower median alkaloid levels after the EU limit was introduced, despite sporadic exceedances. [7]
- In 80 South African retail samples, chromium ranged from 0.17 to 11.98 mg/kg and was reported as higher than the 1.3 mg/kg WHO limit the authors cite; hazard indices for the metals tested were below 1. [8]
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; manufacturers and distributors have initial responsibility for their safety. [9]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Aspalathin and nothofagin Dihydrochalcones (flavonoid C-glycosides) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming rooibos (Aspalathus linearis) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No NIH LiverTox chapter on rooibos was found. MSK lists three case reports of liver toxicity or raised liver enzymes with long-term or large intake; in two, liver tests returned to normal after stopping. [P1]
- LiverTox's buchu chapter (updated March 3, 2023) notes a single published case of acute hepatitis in a patient taking both buchu and rooibos herbal tea. [P5]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each dietary-ingredient component (21 CFR 111.75(a)(1)(i)) — Required by the US dietary supplement cGMP rule for any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P6]
- Pyrrolizidine alkaloids (LC-MS/MS) — PAs, mainly Senecio-type, were detected in 98% of 203 European retail rooibos samples and migrated into infusions; the EU maximum level cited is 400 μg/kg. [P7]
- Alternaria mycotoxins (e.g. tenuazonic acid) — Tenuazonic acid was detected in all 203 samples tested and Alternaria toxins migrated into infusions. [P7]
- Heavy metals, including chromium (ICP-MS) — Chromium in 80 South African retail samples ranged from 0.17 to 11.98 mg/kg and was reported as higher than the WHO limit cited by the authors. [P8]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- In a crossover study of 12 healthy men drinking unfermented rooibos, seven aspalathin and nothofagin metabolites plus the intact compounds were found in urine (main metabolite: methylated aspalathin); unchanged aspalathin appeared in plasma only in trace quantities. Flavonoids detected at peak after rooibos tea accounted for 0.26% of the total ingested. [P9]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Memorial Sloan Kettering Cancer Center. About Herbs: Rooibos Tea (last updated February 2, 2023), 2023-02-02. mskcc.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications, Agents classified by the IARC Monographs, Volumes 1–142 (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox (NIDDK). Buchu (Last Update: March 3, 2023), 2023-03-03. ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75 (Title 21 up to date as of 10/27/2026), 2026-10-27. ecfr.gov
- Volkov A, et al. Occurrence of tropane alkaloids, pyrrolizidine alkaloids and mycotoxins in rooibos: a comprehensive safety assessment. Food Addit Contam Part A 2026 (PMID 42615889), 2026-08-19. pubmed.ncbi.nlm.nih.gov
- Areo OM, Njobeh PB. Risk assessment of heavy metals in rooibos (Aspalathus linearis) tea consumed in South Africa. Environ Sci Pollut Res Int 2021 (PMID 34145539), 2021-11. pubmed.ncbi.nlm.nih.gov
- Breiter T, et al. Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations. Food Chem 2011 (PMID 25212140), 2011-09-15. pubmed.ncbi.nlm.nih.gov
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Rooibos Tea (last updated February 2, 2023), 2023-02-02. mskcc.org
- Marnewick JL, et al. Effects of rooibos (Aspalathus linearis) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease. J Ethnopharmacol 2011;133(1):46-52 (PMID 20833235), 2011-01-07. pubmed.ncbi.nlm.nih.gov
- Persson IA, et al. Effects of green tea, black tea and Rooibos tea on angiotensin-converting enzyme and nitric oxide in healthy volunteers. Public Health Nutr 2010;13(5):730-7 (PMID 20144258), 2010-05. pubmed.ncbi.nlm.nih.gov
- Hartnick MD, et al. Impact of Chronic Consumption of Herbal Rooibos on Cardiovascular Function in Adults with Cardiovascular Risk. J Med Food 2024;27(10):905-911 (PMID 38958559), 2024-10. pubmed.ncbi.nlm.nih.gov
- Utter AC, et al. Effects of rooibos tea, bottled water, and a carbohydrate beverage on blood and urinary measures of hydration after acute dehydration. Res Sports Med 2010;18(2):85-96 (PMID 20397112), 2010-04. pubmed.ncbi.nlm.nih.gov
- Sasaki M, et al. A Beneficial Role of Rooibos in Diabetes Mellitus: A Systematic Review and Meta-Analysis. Molecules 2018;23(4):839 (PMID 29642387), 2018-04-06. pubmed.ncbi.nlm.nih.gov
- Volkov A, et al. Occurrence of tropane alkaloids, pyrrolizidine alkaloids and mycotoxins in rooibos: a comprehensive safety assessment. Food Addit Contam Part A 2026 (PMID 42615889), 2026-08-19. pubmed.ncbi.nlm.nih.gov
- Areo OM, Njobeh PB. Risk assessment of heavy metals in rooibos (Aspalathus linearis) tea consumed in South Africa. Environ Sci Pollut Res Int 2021 (PMID 34145539), 2021-11. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data (Govaerts et al., Sci Data 2021). Aspalathus linearis (Burm.f.) R.Dahlgren (accessed 2026-10-29); synonyms from WCVP, 2026-10-29. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.